- Home
- CZNC vs NPCE Comparison
CZNC vs NPCE Comparison
Compare CZNC & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CZNC
- NPCE
- Stock Information
- Founded
- CZNC 1864
- NPCE 1997
- Country
- CZNC United States
- NPCE United States
- Employees
- CZNC N/A
- NPCE N/A
- Industry
- CZNC Major Banks
- NPCE Medical Specialities
- Sector
- CZNC Finance
- NPCE Health Care
- Exchange
- CZNC Nasdaq
- NPCE Nasdaq
- Market Cap
- CZNC 301.8M
- NPCE 292.9M
- IPO Year
- CZNC N/A
- NPCE 2021
- Fundamental
- Price
- CZNC $20.20
- NPCE $9.15
- Analyst Decision
- CZNC
- NPCE Strong Buy
- Analyst Count
- CZNC 0
- NPCE 6
- Target Price
- CZNC N/A
- NPCE $16.67
- AVG Volume (30 Days)
- CZNC 49.3K
- NPCE 205.3K
- Earning Date
- CZNC 08-08-2025
- NPCE 08-12-2025
- Dividend Yield
- CZNC 5.54%
- NPCE N/A
- EPS Growth
- CZNC 15.34
- NPCE N/A
- EPS
- CZNC 1.75
- NPCE N/A
- Revenue
- CZNC $108,310,000.00
- NPCE $88,570,000.00
- Revenue This Year
- CZNC $5.72
- NPCE $22.13
- Revenue Next Year
- CZNC $7.18
- NPCE $6.07
- P/E Ratio
- CZNC $11.57
- NPCE N/A
- Revenue Growth
- CZNC 4.96
- NPCE 23.32
- 52 Week Low
- CZNC $17.85
- NPCE $5.45
- 52 Week High
- CZNC $22.68
- NPCE $18.98
- Technical
- Relative Strength Index (RSI)
- CZNC 58.87
- NPCE 51.74
- Support Level
- CZNC $19.13
- NPCE $8.61
- Resistance Level
- CZNC $20.57
- NPCE $8.99
- Average True Range (ATR)
- CZNC 0.52
- NPCE 0.53
- MACD
- CZNC 0.11
- NPCE 0.11
- Stochastic Oscillator
- CZNC 78.36
- NPCE 75.00
About CZNC Citizens & Northern Corp
Citizens & Northern Corp is a community bank operating through its subsidiaries. It provides banking services, including deposit and loan products for personal and commercial customers. The bank also maintains a trust division that provides a wide range of financial services, such as 401(k) plans, retirement planning, estate planning, estate settlements and asset management.
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.